Cargando…
Atrial Fibrillation Induced by Anticancer Drugs and Underling Mechanisms
Cancer therapy has made major progress in the past several decades, but treatments are often accompanied by significant side effects. Arrhythmias are a widespread complication of some antineoplastic drugs, with atrial fibrillation (AF) being the most often encountered drug-associated arrhythmia. Pre...
Autor principal: | Burashnikov, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Cardiovascular Pharmacology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566596/ https://www.ncbi.nlm.nih.gov/pubmed/34803149 http://dx.doi.org/10.1097/FJC.0000000000001182 |
Ejemplares similares
-
Investigational Anti–Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?
por: Burashnikov, Alexander
Publicado: (2020) -
Role of Pentacyclic Triterpenoids in Chemoprevention and Anticancer Treatment: An Overview on Targets and Underling Mechanisms
por: Ghante, Mahavir H., et al.
Publicado: (2019) -
Atrial fibrillation
por: Munger, Thomas M., et al.
Publicado: (2014) -
Perspectives by a position statement on atrial fibrillation in acute heart failure a: Mechanisms and therapeutic approaches
por: Okutucu, Sercan, et al.
Publicado: (2020) -
Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation
por: Verrier, Richard L., et al.
Publicado: (2020)